pd 153035 has been researched along with Cancer of Liver in 3 studies
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline: structure given in first source
PD-153035 : A member of the class of quinazolines carrying a 3-bromophenylamino substituent at position 4 and two methoxy substituents at positions 6 and 7.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Epidermal growth factor receptor (EGFR) is highly expressed in many human tumors including hepatocellular carcinoma (HCC)." | 7.74 | Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma. ( Chen, H; Fan, ST; Kok, TW; Liu, Y; Poon, RT; Shao, W; Sun, X, 2007) |
| "Epidermal growth factor receptor (EGFR) is highly expressed in many human tumors including hepatocellular carcinoma (HCC)." | 3.74 | Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma. ( Chen, H; Fan, ST; Kok, TW; Liu, Y; Poon, RT; Shao, W; Sun, X, 2007) |
| "Hepatocellular carcinoma is a major cause of cancer-related deaths." | 1.33 | Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells. ( Avila, MA; Berasain, C; Castillo, J; Erroba, E; Lee, DC; Perugorría, MJ; Prieto, J; Santamaría, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X | 1 |
| Lv, Y | 1 |
| Yuan, A | 1 |
| Yi, S | 1 |
| Ma, Y | 1 |
| Li, Z | 1 |
| Castillo, J | 1 |
| Erroba, E | 1 |
| Perugorría, MJ | 1 |
| Santamaría, M | 1 |
| Lee, DC | 1 |
| Prieto, J | 1 |
| Avila, MA | 1 |
| Berasain, C | 1 |
| Liu, Y | 1 |
| Poon, RT | 1 |
| Shao, W | 1 |
| Sun, X | 1 |
| Chen, H | 1 |
| Kok, TW | 1 |
| Fan, ST | 1 |
3 other studies available for pd 153035 and Cancer of Liver
| Article | Year |
|---|---|
Gastrin-releasing peptide promotes the growth of HepG2 cells via EGFR-independent ERK1/2 activation.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Cells, Cultured; En | 2010 |
Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells.
Topics: Aged; Amphiregulin; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Growth Processes; Cell Line, | 2006 |
Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma.
Topics: Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Prolifer | 2007 |